Takeda Pharmaceutical Company Limited Derivative Financial Assets
Takeda Pharmaceutical Company Limited (TKPHF) had Derivative Financial Assets of JPY 84.37 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes › Derivative Instruments and Hedging Activities
ifrs-full:DerivativeFinancialAssets · last filed 2025-06-25
- 2025-03-31: Derivative Financial Assets 84.37B JPY.
- 2024-03-31: Derivative Financial Assets 120.22B JPY.
- 2023-03-31: Derivative Financial Assets 79.65B JPY.
- 2022-03-31: Derivative Financial Assets 41.89B JPY.
| Period end | Derivative Financial Assets |
|---|---|
| 2025-03-31 | 84.37B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 120.22B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 79.65B JPY 20-F · filed 2024-06-26 |
| 2022-03-31 | 41.89B JPY 20-F · filed 2023-06-28 |
| 2021-03-31 | 64.10B JPY 20-F · filed 2022-06-29 |
| 2020-03-31 | 25.63B JPY 20-F · filed 2021-06-29 |
| 2019-03-31 | 8.31B JPY 20-F · filed 2020-06-24 |
| 2018-03-31 | 3.29B JPY 20-F · filed 2019-06-27 |